The US Food and Drug Administration has relaxed some of the rules governing how companies must test the sterility of materials used to make biologic drugs.
The Scientist
Most Recent
The FDA is on board with a proposal to speed the approval of experimental pharmaceuticals that show big treatment effects early in clinical testing.
The diversity of microbes in the great outdoors may protect against inflammatory disorders.
Techniques for simpler, cheaper, and better antibody purification
A cytokine involved in suppressing the immune system may actually activate it to kill cancer cells.
Targeting the briefest moment in chemistry may lead to an exceptionally strong new class of drugs.
A combination of antibiotics and the body’s own defensive metabolites clears bacterial infections faster than antibiotics alone.
New work on salicylate, a natural component of aspirin, suggests that activation of the energy-sensing AMP kinase may underlie some of aspirin’s health benefits.
A novel antibody with a powerful affinity for cocaine shows promise in reversing the deadly effects of an overdose.
Francis Collins says pharmaceutical companies should help bridge the gap between basic science and applications with old drug compounds.
Follow The Scientist
Advertisement
Stay Connected with The Scientist
-
The Scientist Magazine
-
The Scientist Careers
-
Neuroscience Research Techniques
-
Genetic Research Techniques
-
Cell Culture Techniques
-
Microbiology and Immunology
-
Cancer Research and Technology
Current Issue
